Analyzing prior clinical events at presentation in 102 women with vulvar carcinoma. Evidence of diagnostic delays

J Reprod Med. 1999 Sep;44(9):766-8.

Abstract

Objective: To evaluate the clinical events preceding the diagnosis of squamous cell carcinoma of the vulva.

Study design: One hundred two women presenting with squamous cell carcinoma of the vulva to a gynecologic oncology unit between 1989 and 1996 were prospectively evaluated by a single investigator. History, clinical findings, previous physician contact, investigations and treatment were analyzed.

Results: Vulvar symptoms were present for more than six months in 88% and for more than five years in 28% of women. Eighty-five percent of patients had clinical evidence of abnormal skin adjacent to the cancer. Thirty-one percent of women had three or more medical consultations for vulvar symptoms prior to the diagnosis of cancer. Twenty-five percent of women had had a previous diagnostic vulvar biopsy, and 27% gave a history of having applied topical estrogen or corticosteroid to the vulva. Patients with a history of a preceding biopsy were more likely to present with stage 1 disease.

Conclusion: Avoidable factors appear to be present in many women who present with vulvar cancer. A more active approach to the diagnosis and management of precursor lesions may often prevent the development of vulvar cancer.

MeSH terms

  • Adrenal Cortex Hormones / administration & dosage
  • Adult
  • Aged
  • Aged, 80 and over
  • Biopsy
  • Carcinoma, Squamous Cell / diagnosis*
  • Carcinoma, Squamous Cell / pathology
  • Estrogens / administration & dosage
  • Female
  • Humans
  • Middle Aged
  • Vulvar Neoplasms / diagnosis*
  • Vulvar Neoplasms / pathology

Substances

  • Adrenal Cortex Hormones
  • Estrogens